| Current Price | $6.38 | Mkt Cap | $656.7M |
|---|---|---|---|
| Open | $6.34 | P/E Ratio | 0.00 |
| Prev. Close | $6.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.14 - $6.48 | Volume | 2 |
| 52-Wk Range | $2.87 - $8.58 | Avg. Daily Vol. | 3,694,267 |
| Current Price | $6.38 | Mkt Cap | $656.7M |
|---|---|---|---|
| Open | $6.34 | P/E Ratio | 0.00 |
| Prev. Close | $6.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.14 - $6.48 | Volume | 2 |
| 52-Wk Range | $2.87 - $8.58 | Avg. Daily Vol. | 3,694,267 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity or Zacks December 2021:Revenue Growth (Last 5 Years) = 77.9%Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%Price/Sales (TTM) = 14.2Re-establishing this position at a lower price.
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Read the most recent pitches from players about BLUE.
Recs
Car12703
(< 20)
Submitted: 12/20/2021 10:25:57 AM :
Start Price:
$8.32
NASDAQ:BLUE Score:
-13.97
From Fidelity or Zacks December 2021:
Revenue Growth (Last 5 Years) = 77.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%
Price/Sales (TTM) = 14.2
Re-establishing this position at a lower price.
Recs
Ficktory
(29.41)
Submitted: 12/13/2021 2:27:25 PM :
Start Price:
$9.36
NASDAQ:BLUE Score:
-19.66
Gene therapies will be a huge growth sector in health care in the next decade.
Recs
TMFacarchidi
(< 20)
Submitted: 12/1/2021 10:19:45 AM :
Start Price:
$10.58
NASDAQ:BLUE Score:
+28.48
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (< 20) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| secohen11 | 20.72 | 7/2/2013 |
|
1Y | $26.20 | -75.65% | +154.95% | +230.60 | 0 Comment | |
| saab93boi | < 20 | 6/19/2013 |
|
5Y | $25.68 | -75.15% | +149.85% | +225.00 | 0 Comment | |
| rwpaules | 86.67 | 6/19/2013 |
|
3Y | $25.09 | -74.57% | +148.24% | +222.81 | 0 Comment | |
| biotechf | 29.49 | 1/22/2016 |
|
3M | $44.44 | -85.64% | +116.97% | +202.62 | 0 Comment | |
| MotleyFolJohn | < 20 | 2/2/2015 |
|
1Y | $93.98 | -93.21% | +105.72% | +198.93 | 1 Comment | |
|
CommodityBuyer | < 20 | 7/10/2015 |
|
5Y | $160.69 | -96.03% | +98.07% | +194.10 | 0 Comment |
| pro64grammer | 27.96 | 12/9/2014 |
|
5Y | $79.58 | -91.98% | +100.69% | +192.67 | 0 Comment | |
| 3rdChanceTom | 86.53 | 3/11/2016 |
|
5Y | $45.77 | -86.06% | +104.10% | +190.16 | 0 Comment | |
| GreenAB | 28.70 | 3/5/2015 |
|
NS | $106.20 | -93.99% | +94.92% | +188.91 | 0 Comment | |
| coptermech66 | < 20 | 10/29/2015 |
|
3Y | $79.54 | -91.98% | +96.72% | +188.70 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
